Status:
NOT_YET_RECRUITING
Catheter Ablation Using a Novel Navigation and Imaging System
Lead Sponsor:
LUMA Vision Ltd.
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paro...
Eligibility Criteria
Inclusion
- Subject is 18 years of age at the time of consent, or of legal age to give informed consent specific to state and national law
- Subjects is eligible for a catheter ablation procedure with the VERAFEYE System as navigation and imaging system in the treatment of PAF (according to VERAFEYE System IFUs, current international and local guidelines and per physician discretion)
- Subject is able to understand and willing to provide written informed consent
- Subject is able to and willing to complete all study assessments associated with this clinical study at an approved clinical investigational center
Exclusion
Key Trial Info
Start Date :
March 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06895187
Start Date
March 1 2026
End Date
March 1 2027
Last Update
December 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.